Cost-Effectiveness Analysis for Surgical, Angioplasty, or Medical Therapeutics for Coronary Artery Disease | Zendy

Ricardo D’Oliveira Vieira | Zendy; Whady Hueb | Zendy; Mark A. Hlatky | Zendy; Desidério Favarato | Zendy; Paulo Cury Rezende | Zendy; Cibele Larrosa Garzillo | Zendy; Eduardo Gomes Lima | Zendy; Paulo Rogério Soares | Zendy; Alexandre Ciappina Hueb | Zendy; Alexandre C. Pereira | Zendy; José Antônio Franchini Ramires | Zendy; Roberto Kalil Filho | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-Effectiveness Analysis for Surgical, Angioplasty, or Medical Therapeutics for Coronary Artery Disease

Author(s) -

Ricardo D’Oliveira Vieira,

Whady Hueb,

Mark A. Hlatky,

Desidério Favarato,

Paulo Cury Rezende,

Cibele Larrosa Garzillo,

Eduardo Gomes Lima,

Paulo Rogério Soares,

Alexandre Ciappina Hueb,

Alexandre C. Pereira,

José Antônio Franchini Ramires,

Roberto Kalil Filho

Publication year - 2012

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.084442

Subject(s) - medicine , conventional pci , percutaneous coronary intervention , angina , angioplasty , cardiology , coronary artery disease , artery , unstable angina , coronary artery bypass surgery , left main coronary artery disease , surgery , coronary heart disease , myocardial infarction

The Second Medicine, Angioplasty, or Surgery Study (MASS II) included patients with multivessel coronary artery disease and normal systolic ventricular function. Patients underwent coronary artery bypass graft surgery (CABG, n=203), percutaneous coronary intervention (PCI, n=205), or medical treatment alone (MT, n=203). This investigation compares the economic outcome at 5-year follow-up of the 3 therapeutic strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research